Literature DB >> 4579900

Preliminary characterization of "immunogenic" ribonucleic acid derived from rat peritoneal exudate cells.

S J Archer, C J Wust.   

Abstract

An "immunogenic" ribonucleic acid (Im-RNA) has been extracted from peritoneal exudate (PE) cells of rats that were immunized with sheep erythrocytes (SRBC). Following multiple phenol extractions and deoxyribonuclease treatment, the material obtained from PE cells was eluted from diethylaminoethyl-cellulose at 0.55 M NaCl concentration and partially purified in this procedure by a factor of 7- to 10-fold. After column chromatography, Im-RNA was found to be free of antigen based on results using (51)Cr-labeled SRBC or (14)C-dinitrophenol coupled to methylated bovine serum albumin as antigens. The Im-RNA showed a biphasic hyperchromicity curve when heated. The first phase, from 30 C to 90 C was gradual, accounting for 15.2% hyperchromicity suggestive of transfer RNA melting. No loss in immunogenic activity was observed when the Im-RNA was heated to 90 C. The second phase, from 90 C to 102 C, accounting for 15.2% further hyperchromicity, had a calculated T(m) of 96 C. Heating above 90 C resulted in an irreversible loss of immunogenic activity. These results strongly suggested that the RNA fraction contained a highly ordered secondary structure such as might be found with double-stranded nucleic acid. The nature and function of the Im-RNA is discussed.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4579900      PMCID: PMC422835          DOI: 10.1128/iai.8.2.215-221.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  IMMUNOGENICITY OF ANTIGEN-CONTAINING RIBONUCLEIC ACID PREPARATIONS FROM MACROPHAGES.

Authors:  B A ASKONAS; J M RHODES
Journal:  Nature       Date:  1965-01-30       Impact factor: 49.962

2.  Resistance of S-RNA to ribonucleases in the presence of magnesium ion.

Authors:  S NISHIMURA; G D NOVELLI
Journal:  Biochem Biophys Res Commun       Date:  1963-05-03       Impact factor: 3.575

Review 3.  Multiple cellular and subcellular responses to antigen. Literature review and hypothesis of immunization.

Authors:  R S Speirs
Journal:  Immunochemistry       Date:  1971-07

4.  Isoaccepting +RNA's in mouse plasma cell tumors that synthesize different myeloma protein.

Authors:  W K Yang; G D Novelli
Journal:  Biochem Biophys Res Commun       Date:  1968-05-23       Impact factor: 3.575

5.  Antibody formation against 2,4-dinitrophenyl-hapten at the cellular level. Hemolytic plaque-in-gel assay for lymphoid cells producing anti-2,4-dinitrophenyl-hapten antibody.

Authors:  H Yamada; A Yamada
Journal:  J Immunol       Date:  1969-08       Impact factor: 5.422

6.  Fate and immunogenicity of antigens endocytosed by macrophages: a study using foreign red cells and immunoglobulin G.

Authors:  A Cruchaud; E R Unanue
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

7.  Conversion of non-immune spleen cells by ribonucleic acid of lymphoid cells from an immunized rabbit to produce gammaM antibody of foreign light chain allotype.

Authors:  C Bell; S Dray
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

8.  Macrophage functional heterogeneity in the in vitro induced immune response.

Authors:  W S Walker
Journal:  Nat New Biol       Date:  1971-02-17

9.  Mechanism of antibody biosynthesis. I. Isolation and physical chemical properties of the retained antigen.

Authors:  S Harshman; L J Duke; H Six
Journal:  Immunochemistry       Date:  1969-03

10.  Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes.

Authors:  J F Miller; G F Mitchell
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

View more
  1 in total

1.  Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis.

Authors:  I I Andron LA; H T Eigelsbach
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.